The Food and Drug Administration announced on Friday that they have approved a groundbreaking cellular therapy treatment to treat patients with advanced melanoma whose surgery has failed. Amtagvi is a type T-cell therapy that boosts immune cells in tumor tissue to help fight cancer. During treatment, the patient’s t-cells…
The Food and Drug Administration (FDA) announced Friday that it approved a ground breaking cellular therapy treatment for patients with advanced melanoma, and surgery has been unsuccessful. Amtagvi, a type of T-cell therapy, involves boosting immune cells within tumor tissue to help the body fight off the cancer. During the treatment, the patient’s t-cells are… The Food and Drug Administration (FDA) announced Friday that it approved a ground breaking cellular therapy treatment for patients with advanced melanoma, and surgery has been unsuccessful. Amtagvi, a type of T-cell therapy, involves boosting immune cells within tumor tissue to help the body fight off the cancer. During the treatment, the patient’s t-cells are…
The Food and Drug Administration announced on Friday that they have approved a groundbreaking cellular therapy treatment to treat patients with advanced melanoma whose surgery has failed. Amtagvi is a type T-cell therapy that boosts immune cells in tumor tissue to help fight cancer. During treatment, the patient’s t-cells…
